CMPS COMPASS PATHWAYS PLC Investments/Divestments 8-K Filing 2024 - Positive Study Results Compass Pathways reported positive results from a phase 2 study on the safety and efficacy of COMP360 psilocybin treatment for PTSD, with significant symptom improvement observed.Get access to all SEC 8-K filings of the COMPASS PATHWAYS PLC